98 related articles for article (PubMed ID: 8789735)
1. Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells.
Carruba G; Granata OM; Farruggio R; Cannella S; Bue AL; Leake RE; Pavone-Macaluso M; Castagnetta LA
Steroids; 1996 Jan; 61(1):41-6. PubMed ID: 8789735
[TBL] [Abstract][Full Text] [Related]
2. Different conversion metabolic rates of testosterone are associated to hormone-sensitive status and -response of human prostate cancer cells.
Castagnetta L; Granata OM; Polito L; Blasi L; Cannella S; Carruba G
J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):351-7. PubMed ID: 8043500
[TBL] [Abstract][Full Text] [Related]
3. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells.
Carruba G; Leake RE; Rinaldi F; Chalmers D; Comito L; Sorci C; Pavone-Macaluso M; Castagnetta LA
Steroids; 1994 Jul; 59(7):412-20. PubMed ID: 7974525
[TBL] [Abstract][Full Text] [Related]
4. Androgens regulate proliferation of human prostate cancer cells in culture by increasing transforming growth factor-alpha (TGF-alpha) and epidermal growth factor (EGF)/TGF-alpha receptor.
Liu XH; Wiley HS; Meikle AW
J Clin Endocrinol Metab; 1993 Dec; 77(6):1472-8. PubMed ID: 8263129
[TBL] [Abstract][Full Text] [Related]
5. Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC
du Toit T; Bloem LM; Quanson JL; Ehlers R; Serafin AM; Swart AC
J Steroid Biochem Mol Biol; 2017 Feb; 166():54-67. PubMed ID: 27345701
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of anchorage independent growth of human prostate cancer cell line LNCap].
Hara Y
Nihon Hinyokika Gakkai Zasshi; 1992 Sep; 83(9):1429-35. PubMed ID: 1434284
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 is a mediator of androgen-regulated growth arrest in an androgen-responsive prostatic cancer cell line, LNCaP.
Kim IY; Kim JH; Zelner DJ; Ahn HJ; Sensibar JA; Lee C
Endocrinology; 1996 Mar; 137(3):991-9. PubMed ID: 8603613
[TBL] [Abstract][Full Text] [Related]
9. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
Yang Y; Chisholm GD; Habib FK
Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
[TBL] [Abstract][Full Text] [Related]
11. Androgen metabolism in the human prostatic cancer cell line LNCaP.
Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):89-96. PubMed ID: 7947355
[TBL] [Abstract][Full Text] [Related]
12. Comparison of testosterone metabolism in benign prostatic hyperplasia and human prostate cancer cell lines in vitro.
Smith CM; Ballard SA; Wyllie MG; Masters JR
J Steroid Biochem Mol Biol; 1994 Aug; 50(3-4):151-9. PubMed ID: 7519439
[TBL] [Abstract][Full Text] [Related]
13. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
14. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
Limonta P; Dondi D; Marelli MM; Moretti RM; Negri-Cesi P; Motta M
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487
[TBL] [Abstract][Full Text] [Related]
15. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro.
Wilding G; Zugmeier G; Knabbe C; Flanders K; Gelmann E
Mol Cell Endocrinol; 1989 Mar; 62(1):79-87. PubMed ID: 2545487
[TBL] [Abstract][Full Text] [Related]
17. Alterations of expression and regulation of transforming growth factor beta in human cancer prostate cell lines.
Blanchère M; Saunier E; Mestayer C; Broshuis M; Mowszowicz I
J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):297-304. PubMed ID: 12589936
[TBL] [Abstract][Full Text] [Related]
18. Androgen metabolism in tissue recombinants composed of adult urinary bladder epithelium and urogenital sinus mesenchyme.
Neubauer BL; Anderson NG; Cunha GR; Towell JF; Chung LW
J Steroid Biochem; 1985 Jul; 23(1):95-101. PubMed ID: 4021496
[TBL] [Abstract][Full Text] [Related]
19. Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells.
Ripple MO; Henry WF; Rago RP; Wilding G
J Natl Cancer Inst; 1997 Jan; 89(1):40-8. PubMed ID: 8978405
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 antagonizes the combined apoptotic effect of transforming growth factor-beta and dihydrotestosterone in prostate cancer cells.
Bruckheimer EM; Kyprianou N
Prostate; 2002 Oct; 53(2):133-42. PubMed ID: 12242728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
